Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Cogent Biosciences Inc (NASDAQ: COGT) closed at $4.77 down -10.51% from its previous closing price of $5.33. In other words, the price has decreased by -$10.51 from its previous closing price. On the day, 2.06 million shares were traded. COGT stock price reached its highest trading level at $5.22 during the session, while it also had its lowest trading level at $4.63.
Ratios:
For a deeper understanding of Cogent Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.32 and its Current Ratio is at 5.32. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $17.
Robert W. Baird Downgraded its Outperform to Neutral on February 26, 2024, whereas the target price for the stock was revised from $14 to $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 14 ’25 when Pinnow Cole bought 43,750 shares for $7.60 per share. The transaction valued at 332,412 led to the insider holds 45,848 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COGT now has a Market Capitalization of 543064512 and an Enterprise Value of 368261312.
Stock Price History:
The Beta on a monthly basis for COGT is 1.93, which has changed by -0.2684049 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, COGT has reached a high of $12.61, while it has fallen to a 52-week low of $5.30. The 50-Day Moving Average of the stock is -37.17%, while the 200-Day Moving Average is calculated to be -47.61%.
Shares Statistics:
For the past three months, COGT has traded an average of 1.39M shares per day and 1609890 over the past ten days. A total of 110.46M shares are outstanding, with a floating share count of 95.39M. Insiders hold about 16.22% of the company’s shares, while institutions hold 91.51% stake in the company. Shares short for COGT as of 1741910400 were 11839050 with a Short Ratio of 8.54, compared to 1739491200 on 10801457. Therefore, it implies a Short% of Shares Outstanding of 11839050 and a Short% of Float of 11.4700004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Cogent Biosciences Inc (COGT) is currently in the spotlight, with 7.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.39 and low estimates of -$0.66.
Analysts are recommending an EPS of between -$1.58 and -$2.65 for the fiscal current year, implying an average EPS of -$2.18. EPS for the following year is -$1.77, with 7.0 analysts recommending between -$1.32 and -$2.58.
